Sunshine Biopharma Inc. Other Comprehensive Income (Loss), Net of Tax
Sunshine Biopharma Inc. (SBFM) reported Other Comprehensive Income (Loss), Net of Tax of -$115 for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-13.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2019-11-13
- Sunshine Biopharma Inc. other comprehensive income (loss), net of tax for the quarter ending 2019-09-30 was -$115.00, a 100.96% decline year-over-year.
- Sunshine Biopharma Inc. other comprehensive income (loss), net of tax for the quarter ending 2019-06-30 was $2.50K.
- Sunshine Biopharma Inc. other comprehensive income (loss), net of tax for the quarter ending 2018-09-30 was $12.00K.
- Sunshine Biopharma Inc. other comprehensive income (loss), net of tax for the quarter ending 2018-06-30 was -$6.03K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month |
|---|---|---|---|
| 2019-09-30 | -$115.00 10-Q · filed 2019-11-13 | $2.38K derived: sum of 2 quarters · filed 2019-11-13 | $1.60K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $2.50K 10-Q · filed 2019-08-15 | $1.71K 10-Q · filed 2019-08-15 | |
| 2018-09-30 | $12.00K 10-Q · filed 2019-11-13 | $5.97K derived: sum of 2 quarters · filed 2019-11-13 | $3.23K 10-Q · filed 2019-11-13 |
| 2018-06-30 | -$6.03K 10-Q · filed 2019-08-15 | -$8.77K 10-Q · filed 2019-08-15 | |
| 2018-03-31 | -$2.74K 10-Q · filed 2019-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |